Income Statement Alliance Pharma plc

Equities

APH

GB0031030819

Pharmaceuticals

Delayed London S.E. Other stock markets 13:02:58 19/09/2024 BST			5-day change	1st Jan Change
41.80 ^GBX	+9,996.14%		-1.42%	+3.20%

09-02	Alliance Pharma plc Announces Termination of Jeyan Heper as Director	CI
08-12	EXECUTIVE CHANGES: New chief executives at Cornish Metals and ValiRx	AN

c07a2bc6074.SgDJV2oJkQVY6xEN7KXnhG2i-hlMxI-vsgGhufSJEq4.LmOfGAk5wWcCpSZvvfC95h6Vm2gJ8fvBn0fn_b_cUeM-ePAGXzrQbS6qcg

Published financial data: ALLIANCE PHARMA PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	136M	130M	163M	167M	181M
Total Revenues	136M	130M	163M	167M	181M
Cost of Goods Sold, Total	49.56M	46.98M	53.76M	65.73M	75.66M
Gross Profit	86.08M	82.82M	109M	102M	105M
Selling General & Admin Expenses, Total	46.81M	44.61M	60.62M	63.96M	52.47M
Stock-Based Compensation (IS)	1.82M	1.37M	2.25M	92K	889K
Amortization of Goodwill and Intangible Assets - (IS)	-	7.16M	8.53M	9.2M	9.1M
Other Operating Expenses, Total	48.63M	53.14M	71.4M	73.25M	62.46M
Operating Income	37.45M	29.67M	38.04M	28.43M	42.56M
Interest Expense, Total	-3.78M	-2.66M	-3.65M	-5.43M	-9.99M
Interest And Investment Income	23K	10K	23K	16K	113K
Net Interest Expenses	-3.75M	-2.65M	-3.62M	-5.42M	-9.88M
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-799K	-653K	205K	56K	-480K
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	32.89M	26.37M	34.63M	23.07M	32.2M
Restructuring Charges	-	-	-2.42M	-	-
Merger & Related Restructuring Charges	-	-1.3M	-	369K	-
Impairment of Goodwill	-	-1.14M	-	-11.95M	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-145K	-	-	-	-
Asset Writedown	-	-10.91M	-6.15M	-6.28M	-79.25M
Other Unusual Items	-1.67M	-	-7.9M	-	-1.75M
EBT, Incl. Unusual Items	31.08M	13.02M	18.16M	5.21M	-48.8M
Income Tax Expense	6.07M	4.99M	10.84M	4.27M	-15.66M
Earnings From Continuing Operations	25.01M	8.03M	7.32M	936K	-33.14M
Net Income to Company	25.01M	8.03M	7.32M	936K	-33.14M
Net Income - (IS)	25.01M	8.03M	7.32M	936K	-33.14M
Net Income to Common Incl Extra Items	25.01M	8.03M	7.32M	936K	-33.14M
Net Income to Common Excl. Extra Items	25.01M	8.03M	7.32M	936K	-33.14M
Per Share Items
Net EPS - Basic	0.05	0.02	0.01	0	-0.06
Basic EPS - Continuing Operations	0.05	0.02	0.01	0	-0.06
Basic Weighted Average Shares Outstanding	521M	531M	535M	539M	540M
Net EPS - Diluted	0.05	0.01	0.01	0	-0.06
Diluted EPS - Continuing Operations	0.05	0.01	0.01	0	-0.06
Diluted Weighted Average Shares Outstanding	530M	537M	542M	545M	540M
Normalized Basic EPS	0.04	0.03	0.04	0.03	0.04
Normalized Diluted EPS	0.04	0.03	0.04	0.03	0.04
Dividend Per Share	0.01	0.02	0.02	0.02	-
Payout Ratio	30.37	35.34	117.56	973.93	-28.95
Supplemental Items
EBITDA	38.37M	37.78M	45.87M	36.38M	50.23M
EBITA	37.62M	36.83M	45.21M	35.67M	49.76M
EBIT	37.45M	29.67M	38.04M	28.43M	42.56M
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	19.52	38.33	59.69	82.03	32.1
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	4.15M	4.29M	6M	5.78M	5M
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	1.92M	695K	4.83M	-1.51M	-20.67M
Normalized Net Income	20.56M	16.48M	21.64M	14.42M	20.13M
Interest on Long-Term Debt	586K	669K	742K	765K	573K
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	74K	-	-	-	-
Net Rental Expense, Total	-	-	-	-	-
Imputed Operating Lease Interest Expense	-	-	-	-	-
Imputed Operating Lease Depreciation	-	-	-	-	-
Stock-Based Comp., Other (Total)	1.82M	1.37M	2.25M	92K	889K
Total Stock-Based Compensation	1.82M	1.37M	2.25M	92K	889K

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	17.83M	28.9M	29.06M	31.71M	22.44M
Total Cash And Short Term Investments	17.83M	28.9M	29.06M	31.71M	22.44M
Accounts Receivable, Total	23.99M	19.83M	25.75M	44.76M	49.37M
Other Receivables	6.3M	4.38M	1.97M	3.47M	2.32M
Total Receivables	30.29M	24.22M	27.72M	48.23M	51.69M
Inventory	15.52M	22.92M	21.08M	24.29M	25.71M
Prepaid Expenses	703K	898K	3.1M	1.09M	3.03M
Other Current Assets, Total	697K	310K	64K	157K	1.23M
Total Current Assets	65.04M	77.24M	81.02M	105M	104M
Gross Property Plant And Equipment	8.01M	9.28M	10.11M	9.25M	10.35M
Accumulated Depreciation	-3.79M	-4.79M	-5.65M	-4.01M	-4.87M
Net Property Plant And Equipment	4.22M	4.49M	4.46M	5.24M	5.48M
Long-term Investments	-	-	-	-	-
Goodwill	16.53M	31.26M	31.24M	21.53M	14.49M
Other Intangibles, Total	319M	393M	383M	400M	286M
Deferred Tax Assets Long-Term	1.71M	2.14M	3.53M	4.12M	4.65M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	676K	682K	371K	605K	481K
Total Assets	408M	509M	503M	537M	415M
Liabilities
Accounts Payable, Total	6.97M	11.28M	8.34M	18.57M	18.22M
Accrued Expenses, Total	13.36M	16.08M	20.28M	15.52M	17.37M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	47K	-	-	-	-
Current Portion of Leases	1.02M	964K	456K	613K	768K
Current Income Taxes Payable	2.34M	1.44M	1.18M	2.98M	2.45M
Other Current Liabilities	459K	433K	10.32M	9.34M	1.76M
Total Current Liabilities	24.21M	30.19M	40.58M	47.02M	40.57M
Long-Term Debt	77.04M	138M	116M	134M	114M
Long-Term Leases	2M	2.73M	2.43M	3.22M	3M
Deferred Tax Liability Non Current	29.81M	56.18M	61.73M	65.57M	37.86M
Other Non Current Liabilities	404K	469K	211K	196K	1.97M
Total Liabilities	133M	228M	221M	250M	197M
Common Stock, Total	5.29M	5.33M	5.38M	5.4M	5.4M
Additional Paid In Capital	149M	151M	151M	152M	152M
Retained Earnings	113M	118M	116M	108M	43.37M
Comprehensive Income and Other	7.34M	7.28M	9.36M	22.37M	17.42M
Total Common Equity	274M	281M	282M	288M	218M
Total Equity	274M	281M	282M	288M	218M
Total Liabilities And Equity	408M	509M	503M	537M	415M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	529M	533M	538M	540M	540M
ECS Total Common Shares Outstanding	529M	533M	538M	540M	540M
Book Value / Share	0.52	0.53	0.52	0.53	0.4
Tangible Book Value	-61.82M	-143M	-132M	-134M	-82.35M
Tangible Book Value Per Share	-0.12	-0.27	-0.24	-0.25	-0.15
Total Debt	80.11M	142M	119M	138M	117M
Net Debt	62.28M	113M	89.88M	106M	94.98M
Debt Equivalent Oper. Leases	-	-	-	-	-
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	-	-	-	5.08M	5.3M
Inventories - Work In Process, Total	-	-	-	416K	363K
Inventories - Finished Goods, Total	-	-	-	21.8M	23.24M
Inventories - Others	19.09M	25.92M	24.31M	-	-
Machinery, Total	2.71M	2.54M	3.8M	4.02M	4.62M
Full Time Employees	200	245	256	285	292
Accumulated Allowance for Doubtful Accounts (Supple)	999K	641K	851K	411K	424K

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	25.01M	8.03M	7.32M	936K	-33.14M
Depreciation & Amortization - CF	1.5M	1.75M	1.58M	1.56M	1.22M
Amortization of Goodwill and Intangible Assets - (CF)	179K	7.16M	7.17M	7.24M	7.2M
Depreciation & Amortization, Total	1.68M	8.91M	8.74M	8.8M	8.42M
Amortization of Deferred Charges, Total - (CF)	491K	581K	2M	2.61M	2.36M
(Gain) Loss From Sale Of Asset	-	308K	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-	-	-	-	-
Asset Writedown & Restructuring Costs	284K	12.06M	6.15M	18.23M	79.25M
(Income) Loss On Equity Investments - (CF)	-	-	-	-	-
Stock-Based Compensation (CF)	1.82M	1.37M	2.25M	92K	889K
Other Operating Activities, Total	8.74M	2.86M	7.36M	5.03M	-12.19M
Change In Accounts Receivable	-498K	6.73M	-6.15M	-18.72M	-6.48M
Change In Inventories	2.04M	-5.21M	1.84M	-2.21M	-1.86M
Change In Accounts Payable	-3.8M	5.93M	-326K	7.28M	1.94M
Change in Other Net Operating Assets	-	-	9.47M	-1.08M	-7.78M
Cash from Operations	35.76M	41.57M	38.66M	20.97M	31.41M
Capital Expenditure	-4.14M	-4.61M	-1.53M	-358K	-696K
Cash Acquisitions	-	-82.67M	183K	-16.62M	-222K
Sale (Purchase) of Intangible assets	338K	1.4M	-3.26M	-249K	-
Investment in Marketable and Equity Securities, Total	500K	-	-	-	-
Other Investing Activities, Total	23K	10K	-	200K	-
Cash from Investing	-3.28M	-85.86M	-4.6M	-17.02M	-918K
Long-Term Debt Issued, Total	1.05M	82.6M	-	14.92M	-
Total Debt Issued	1.05M	82.6M	-	14.92M	-
Long-Term Debt Repaid, Total	-19.26M	-22.42M	-23.51M	-2.22M	-18.87M
Total Debt Repaid	-19.26M	-22.42M	-23.51M	-2.22M	-18.87M
Issuance of Common Stock	4.51M	1.64M	736K	341K	37K
Common Dividends Paid	-7.6M	-2.84M	-8.6M	-9.12M	-9.59M
Common & Preferred Stock Dividends Paid	-7.6M	-2.84M	-8.6M	-9.12M	-9.59M
Other Financing Activities, Total	-3.91M	-3.23M	-2.96M	-4.8M	-10.77M
Cash from Financing	-25.2M	55.75M	-34.34M	-876K	-39.19M
Foreign Exchange Rate Adjustments	-339K	-384K	447K	-418K	-577K
Net Change in Cash	6.94M	11.07M	163K	2.65M	-9.28M
Supplemental Items
Cash Interest Paid	2.5M	2.87M	2.96M	4.8M	9.43M
Cash Income Tax Paid (Refund)	3.2M	4.84M	6.26M	3.96M	5.52M
Levered Free Cash Flow	21.76M	29.5M	36.99M	9.75M	16.84M
Unlevered Free Cash Flow	23.63M	30.57M	38.63M	12.5M	22.62M
Change In Net Working Capital	-540K	-4.95M	-7.28M	15.52M	14.5M
Net Debt Issued / Repaid	-18.2M	60.17M	-23.51M	12.7M	-18.87M

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	5.77	4.05	4.7	3.41	5.76
Return on Total Capital	6.63	4.77	5.77	4.3	7.21
Return On Equity %	9.5	2.89	2.6	0.33	-13.71
Return on Common Equity	9.5	2.89	2.6	0.33	-13.71
Margin Analysis
Gross Profit Margin %	63.46	63.8	67.06	60.74	58.12
SG&A Margin	34.51	34.37	37.15	38.2	29.04
EBITDA Margin %	28.29	29.11	28.11	21.73	27.8
EBITA Margin %	27.74	28.37	27.7	21.31	27.54
EBIT Margin %	27.61	22.86	23.31	16.98	23.56
Income From Continuing Operations Margin %	18.44	6.18	4.48	0.56	-18.34
Net Income Margin %	18.44	6.18	4.48	0.56	-18.34
Net Avail. For Common Margin %	18.44	6.18	4.48	0.56	-18.34
Normalized Net Income Margin	15.16	12.7	13.26	8.61	11.14
Levered Free Cash Flow Margin	16.04	22.72	22.67	5.82	9.32
Unlevered Free Cash Flow Margin	17.42	23.55	23.67	7.46	12.52
Asset Turnover
Asset Turnover	0.33	0.28	0.32	0.32	0.39
Fixed Assets Turnover	35.9	29.81	36.46	34.54	33.73
Receivables Turnover (Average Receivables)	5.72	5.92	7.16	4.75	3.84
Inventory Turnover (Average Inventory)	2.9	2.44	2.44	2.9	3.03
Short Term Liquidity
Current Ratio	2.69	2.56	2	2.24	2.57
Quick Ratio	1.99	1.76	1.4	1.7	1.83
Operating Cash Flow to Current Liabilities	1.48	1.38	0.95	0.45	0.77
Days Sales Outstanding (Average Receivables)	63.77	61.78	50.97	76.86	95.08
Days Outstanding Inventory (Average Inventory)	126.02	149.7	149.35	125.94	120.6
Average Days Payable Outstanding	62.76	61.39	68.96	71.23	87.1
Cash Conversion Cycle (Average Days)	127.03	150.09	131.36	131.58	128.57
Long Term Solvency
Total Debt/Equity	29.22	50.55	42.11	47.83	53.89
Total Debt / Total Capital	22.61	33.58	29.63	32.35	35.02
LT Debt/Equity	28.83	50.21	41.94	47.61	53.54
Long-Term Debt / Total Capital	22.31	33.35	29.52	32.21	34.79